GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (XPAR:ALMKT) » Definitions » Institutional Ownership

Mauna Kea Technologies (XPAR:ALMKT) Institutional Ownership : 1.21% (As of Jun. 04, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mauna Kea Technologies's institutional ownership is 1.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mauna Kea Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mauna Kea Technologies's Float Percentage Of Total Shares Outstanding is 0.00%.


Mauna Kea Technologies Institutional Ownership Historical Data

The historical data trend for Mauna Kea Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Institutional Ownership Chart

Mauna Kea Technologies Historical Data

The historical data trend for Mauna Kea Technologies can be seen below:

2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 0.47 1.78 1.76 1.76 1.76 1.16 1.16 1.16 1.21 1.21

Mauna Kea Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Mauna Kea Technologies (XPAR:ALMKT) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (XPAR:ALMKT) Headlines

No Headlines